Literature DB >> 9114957

Infectious bursal disease virus: a review of molecular basis for variations in antigenicity and virulence.

M M Nagarajan1, F S Kibenge.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114957      PMCID: PMC1189382     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


× No keyword cloud information.
  63 in total

Review 1.  Immunosuppression induced by infectious bursal disease virus.

Authors:  Y M Saif
Journal:  Vet Immunol Immunopathol       Date:  1991-11       Impact factor: 2.046

2.  Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus.

Authors:  A A Azad; M N Jagadish; M A Brown; P J Hudson
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

3.  Localization of a VP3 epitope of infectious bursal disease virus.

Authors:  M N Jagadish; A A Azad
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

4.  Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus.

Authors:  V Oppling; H Müller; H Becht
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Genomic structure of the large RNA segment of infectious bursal disease virus.

Authors:  P J Hudson; N M McKern; B E Power; A A Azad
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

6.  Active cross-protection induced by a recombinant baculovirus expressing chimeric infectious bursal disease virus structural proteins.

Authors:  D B Snyder; V N Vakharia; S A Mengel-Whereat; G H Edwards; P K Savage; D Lütticken; M A Goodwin
Journal:  Avian Dis       Date:  1994 Oct-Dec       Impact factor: 1.577

Review 7.  Infectious bursal disease of poultry: antigenic structure of the virus and control.

Authors:  H Müller; D Schnitzler; F Bernstein; H Becht; D Cornelissen; D H Lütticken
Journal:  Vet Microbiol       Date:  1992-11       Impact factor: 3.293

8.  Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains.

Authors:  H G Heine; M Haritou; P Failla; K Fahey; A Azad
Journal:  J Gen Virol       Date:  1991-08       Impact factor: 3.891

9.  Apoptosis induced by infectious bursal disease virus.

Authors:  A C Vasconcelos; K M Lam
Journal:  J Gen Virol       Date:  1994-07       Impact factor: 3.891

10.  Sequence of the small double-stranded RNA genomic segment of infectious bursal disease virus and its deduced 90-kDa product.

Authors:  M M Morgan; I G Macreadie; V R Harley; P J Hudson; A A Azad
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

View more
  13 in total

1.  VP1, the putative RNA-dependent RNA polymerase of infectious bursal disease virus, forms complexes with the capsid protein VP3, leading to efficient encapsidation into virus-like particles.

Authors:  E Lombardo; A Maraver; J R Castón; J Rivera; A Fernández-Arias; A Serrano; J L Carrascosa; J F Rodriguez
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Selection of an infectious bursal disease virus mutant with increased immunogenicity following passage under humoral immune pressure.

Authors:  M M Nagarajan; F S Kibenge; A López
Journal:  Can J Vet Res       Date:  2001-04       Impact factor: 1.310

3.  C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly.

Authors:  J R Castón; J L Martínez-Torrecuadrada; A Maraver; E Lombardo; J F Rodríguez; J I Casal; J L Carrascosa
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines.

Authors:  Yakhya Dieye; Arjan J W Hoekman; Florence Clier; Vincent Juillard; Hein J Boot; Jean-Christophe Piard
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

5.  Molecular characterization of two Bangladeshi infectious bursal disease virus isolates using the hypervariable sequence of VP2 as a genetic marker.

Authors:  Md Taohidul Islam; Thanh Hoa Le; Md Mostafizur Rahman; Md Alimul Islam
Journal:  J Vet Sci       Date:  2012-12       Impact factor: 1.672

6.  Chondroitin sulfate N-acetylgalactosaminyltransferase-2 contributes to the replication of infectious bursal disease virus via interaction with the capsid protein VP2.

Authors:  Lizhou Zhang; Xiangang Ren; Yuming Chen; Yulong Gao; Nian Wang; Zhen Lu; Li Gao; Liting Qin; Yongqiang Wang; Honglei Gao; Kai Li; Lili Jiang; Hongyu Cui; Changjun Liu; Yanping Zhang; Xiaole Qi; Xiaomei Wang
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

Review 7.  The Infectious Pancreatic Necrosis Virus (IPNV) and its Virulence Determinants: What is Known and What Should be Known.

Authors:  Carlos P Dopazo
Journal:  Pathogens       Date:  2020-02-04

8.  Partial VP1 sequencing of Brazilian infectious bursal disease virus strains.

Authors:  Maria Judite Bittencourt Fernandes; Isabela Cristina Simoni; Ricardo Harakava; Eliana Borges Rivas; Clarice Weis Arns
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

9.  Gingyo-san enhances immunity and potentiates infectious bursal disease vaccination.

Authors:  Che-Ming Hung; Chia-Chou Yeh; Kowit-Yu Chong; Hsiao-Ling Chen; Jiun-Yu Chen; Shung-Te Kao; Chih-Ching Yen; Ming-Hsien Yeh; Maw-Sun Lin; Chuan-Mu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-25       Impact factor: 2.629

10.  Sequencing and phylogenetic analysis of the infectious bursal disease virus isolates from outbreak in layer flocks in the state of Minas Gerais.

Authors:  Camila Cristina Almeida Dias; Fernanda de Oliveira Souza; Elisa Monteiro Sant' Anna da Silva; Monique Renon Eller; Priscilla Rochele Barrios; Bernadete Miranda Dos Santos; Mauro Pires Moraes; Márcia Rogéria de Almeida
Journal:  Braz J Microbiol       Date:  2009-03-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.